It has been quite an eventful couple of summer months. Touchstone Innovations, the commercialisation firm spun out from Imperial College London, now faces the very real prospect of a hostile takeover by its peer IP Group, after the latter secured the approval of 90% of the target’s shareholders.

The UK government was also busy, with the Treasury finally releasing its consultation on the long-awaited – and somewhat dreaded – patient capital review. The document invites a deeper analysis of what…